Treatment of childhood T-cell lymphoblastic lymphoma according to the strategy for acute lymphoblastic leukaemia, without radiotherapy: Long term results of the EORTC CLG 58881 trial

European Journal of Cancer

Volumn 44, Issue 6, 2008, Pages 840-846

  Uyttebroeck, Anne ^a   Suciu, Stefan ^b   Laureys, Geneviève ^c   Robert, Alain ^d   Pacquement, Hélène ^e   Ferster, Alina ^f   Marguerite, Geneviève ^g   Mazingue, Françoise ^h   Renard, Marleen ^a   Lutz, Patrick ⁱ   Rialland, Xavier ^j   Mechinaud, Françoise ^k   Cavé, Hélène ^l   Baila, Liliana ^b   Bertrand, Yves ^m  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b EORTC DATA CENTER   (Belgium)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d HÔPITAL DES ENFANTS   (France)

^e INSTITUT CURIE   (France)

^f HUDE   (Belgium)

^g HÔPITAL ARNAUD DE VILLENEUVE   (France)

^h LILLE UNIVERSITY HOSPITAL   (France)

ⁱ HÔPITAL DE HAUTEPIERRE   (France)

^j ANGERS UNIVERSITY HOSPITAL   (France)

^k HÔTEL DIEU   (France)

^l HÔPITAL ROBERT DEBRÉ   (France)

^m HÔPITAL DEBROUSSE   (France)

more..

Author keywords

Childhood; Clinical trial; LBL; T cell malignancies

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; FOLINIC ACID; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; TIOGUANINE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER CYTODIAGNOSIS; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILD; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LYMPHOBLASTOMA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME; T CELL LYMPHOBLASTIC LYMPHOMA; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INFANT; MALE; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECURRENCE; TREATMENT OUTCOME;

EID: 41849128437     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.02.011     Document Type: Article

References (20)

1. Sandlund J.T., Downing J.R., and Crist W.M. Non-Hodgkin's lymphoma in childhood. N Engl J Med 334 19 (1996) 1238-1248
2. Eden O.B., Hann I., Imeson J., Cotterill S., Gerrard M., and Pinkerton C.R. Treatment of advanced stage T cell lymphoblastic lymphoma: results of the United Kingdom Children's Cancer Study Group (UKCCSG) protocol 8503. Br J Haematol 82 2 (1992) 310-316
3. Patte C., Kalifa C., Flamant F., et al. Results of the LMT81 protocol, a modified LSA2L2 protocol with high dose methotrexate, on 84 children with non-B-cell (lymphoblastic) lymphoma. Med Pediatr Oncol 20 2 (1992) 105-113
4. Tubergen D.G., Krailo M.D., Meadows A.T., et al. Comparison of treatment regimens for pediatric lymphoblastic non-Hodgkin's lymphoma: a Childrens Cancer Group study. J Clin Oncol 13 6 (1995) 1368-1376
5. Amylon M.D., Shuster J., Pullen J., et al. Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study. Leukemia 13 3 (1999) 335-342
6. Reiter A., Schrappe M., Ludwig W.D., et al. Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report. Blood 95 2 (2000) 416-421
7. Murphy S.B. Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults. Semin Oncol 7 3 (1980) 332-339
8. Harris N.L., Jaffe E.S., Stein H., et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84 5 (1994) 1361-1392
9. Linder J., Ye Y.L., Harrington D.S., Armitage J.O., and Weisenburger D.D. Monoclonal-Antibodies Marking Lymphocytes-T in Paraffin-Embedded Tissue. American Journal of Pathology 127 1 (1987) 1-8
10. Vilmer E., Suciu S., Ferster A., et al. Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. Children Leukemia Cooperative Group. Leukemia 14 12 (2000) 2257-2266
11. Duval M., Suciu S., Ferster A., et al. Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer - Children's Leukemia Group phase 3 trial. Blood 99 8 (2002) 2734-2739
12. van der Werff Ten Bosch J., Suciu S., Thyss A., et al. Value of intravenous 6-mercaptopurine during continuation treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma: final results of a randomized phase III trial (58881) of the EORTC CLG. Leukemia 19 5 (2005) 721-726
13. Millot F., Suciu S., Philippe N., et al. Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial. J Clin Oncol 19 7 (2001) 1935-1942
14. Kalbfleisch J.D., and Prentice R.L. The clinical analysis of failure time date. 2nd ed. (2002), Wiley Inter-Science, New-Jersey
15. Escalon M.P., Liu N.S., Yang Y., et al. Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the M.D. Anderson Cancer Center experience. Cancer 103 10 (2005) 2091-2098
16. Kamps W.A., Bokkerink J.P., Hahlen K., et al. Intensive treatment of children with acute lymphoblastic leukemia according to ALL-BFM-86 without cranial radiotherapy: results of Dutch Childhood Leukemia Study Group Protocol ALL-7 (1988-1991). Blood 94 4 (1999) 1226-1236
17. Reiter A., Schrappe M., Ludwig W.D., et al. Chemotherapy in 998 Unselected Childhood Acute Lymphoblastic-Leukemia Patients - Results and Conclusions of the Multicenter Trial All-Bfm-86. Blood 84 9 (1994) 3122-3133
18. Shuster J.J., Falletta J.M., Pullen D.J., et al. Prognostic factors in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood 75 1 (1990) 166-173
19. Burkhardt B., Zimmermann M., Oschlies I., et al. The impact of age and sex on incidence, biology and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence. Annals of Oncology 16 (2005) 61
20. Mann G., Attarbaschi A., Burkhardt B., et al. Clinical characteristics and treatment outcome of infants with non-Hodgkin lymphoma. Br J Haematol 139 3 (2007) 443-449